These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16702511)

  • 1. Oral involvement in hydroa vacciniforme.
    Wierzbicka E; Malthieu F; Villers A; Guillet G
    Arch Dermatol; 2006 May; 142(5):651. PubMed ID: 16702511
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroa vacciniforme: diagnosis and therapy.
    Goldgeier MH; Nordlund JJ; Lucky AW; Sibrack LA; McCarthy MJ; McGuire J
    Arch Dermatol; 1982 Aug; 118(8):588-91. PubMed ID: 7103528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of recurrent facial herpes simplex mimicking hydroa vacciniforme.
    Uchiyama M; Tsuboi R; Kusunoki T
    Int J Dermatol; 2015 Mar; 54(3):e84-5. PubMed ID: 25516271
    [No Abstract]   [Full Text] [Related]  

  • 4. Two cases of hydroa vacciniforme-like lymphoproliferative disease controlled by anti-inflammatory agents.
    Kim YJ; Choi SY; Lee WJ; Won CH; Chang SE; Choi JH; Lee MW
    Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):287-290. PubMed ID: 28543883
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroa vacciniforme presenting in an adult successfully treated with cyclosporin A.
    Blackwell V; McGregor JM; Hawk JL
    Clin Exp Dermatol; 1998 Mar; 23(2):73-6. PubMed ID: 9692310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroa vacciniforme with unusually severe scar formation: diagnosis by repetitive UVA phototesting.
    Hann SK; Im S; Park YK; Lee S
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):401-3. PubMed ID: 1894782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hydroa vacciniforme and porphyrins metabolism].
    De Dulanto F; Armijo-Moreno M
    Actas Dermosifiliogr; 1968; 59(1):119-28. PubMed ID: 5741143
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hydroa vacciniforme].
    Rebondy JP; Sans B; Bazex J; Cathala-Laurent J
    Ann Dermatol Venereol; 1986; 113(11):1093-5. PubMed ID: 3813399
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroa vacciniforme-like lymphoproliferative disorder in an elderly Chinese patient and a literature review of adult cases.
    Long V; Liang MW; Tan SH
    Int J Dermatol; 2018 Nov; 57(11):1283-1292. PubMed ID: 29926891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroa vacciniforme with oral mucosal involvement.
    Yesudian PD; Sharpe GR
    Pediatr Dermatol; 2004; 21(5):555-7. PubMed ID: 15461761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hydroa vacciniforme as a clinical syndrome of the skin porphyrias and as an independent nosological form].
    Krivosheev BN
    Vestn Dermatol Venerol; 1978 Apr; (4):57-61. PubMed ID: 654532
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroa vacciniforme.
    Ketterer R; Morier P; Frenk E
    Dermatology; 1994; 189(4):428-9. PubMed ID: 7873837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hydroa vacciniforme - action spectrum. UV - tolerance following photochemotherapy].
    Jaschke E; Hönigsmann H
    Hautarzt; 1981 Jul; 32(7):350-3. PubMed ID: 7263243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroa vacciniforme: major and minor forms.
    Cruces MJ; De la Torre C
    Photodermatol; 1986 Apr; 3(2):109-10. PubMed ID: 3703713
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroa vacciniforme in an adolescent girl.
    Raza N; Bari AU; Farooq M
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):359-61. PubMed ID: 17623588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection.
    Katagiri Y; Mitsuhashi Y; Kondo S; Kanazawa C; Iwatsuki K; Tsunoda T
    J Dermatol; 2003 May; 30(5):400-4. PubMed ID: 12773806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic Crohn's disease of the face: an uncommon presentation.
    Kolansky G; Kimbrough-Green C; Dubin HV
    Arch Dermatol; 1993 Oct; 129(10):1348-9. PubMed ID: 8215511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental induction of skin manifestations in hydroa vacciniforme].
    Galosi A; Plewig G; Ring J; Meurer M; Schmoeckel C; Schurig V; Dorn M
    Hautarzt; 1985 Oct; 36(10):566-72. PubMed ID: 4066317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of Favre-Racouchot disease with 0.05% tazarotene gel.
    Rallis E; Karanikola E; Verros C
    Arch Dermatol; 2007 Jun; 143(6):810-2. PubMed ID: 17576962
    [No Abstract]   [Full Text] [Related]  

  • 20. A survey examination of patients with hydroa vacciniforme.
    Kil EH; DeLeo VA
    Cutis; 2011 Nov; 88(5):245-53. PubMed ID: 22272489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.